Cytokinetics, Incorporated <CYTK.O>: Truist Securities Raises Target Price to $112 From $106
CYTK•Related News
Kodiak Gas Services releases investor presentation on natural gas compression and distributed power growth strategy
KGS•
Silo Pharma wins European patent for PTSD prevention therapy SPC-15
SILO•
SHF Holdings Q2 revenue rises 4.8%, net loss widens on deemed dividend
SHFS•
Lincoln Educational Services FY26 Q2 adjusted EBITDA rises 42.4% to $12.7 million; revenue increases 22.4% to $142.6 million
LINC•
FingerMotion says Western Canada grid caps force data centers toward behind-the-meter power generation
FNGR•